Skip to content
Coromandel International logo

Coromandel International

COROMANDEL NSE
₹1,996.00 +24.00 (+1.22%)
Market Cap
₹58,894 Cr
P/E
37.72
View as Markdown
MCP
Close 20 Nov 2026 ₹1,996.00 1Y −305.00 −13.3%
Start ₹2,301.00

Key Fundamentals

MidcapFertilizers & AgrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
22.00%
Debt to Equity
0.12
EPS (TTM)
₹52.91
Book Value
₹454.48
Market Cap
₹58,894 Cr
P/E (TTM)
37.72
P/B
4.39
ROE
16.40%
Dividend Yield
0.56%
EBITDA
₹3,564 Cr
52W High
₹2,499.00
52W Low
₹1,651.10
Day Range
₹1,947.60 – ₹2,020.80
Volume
3,54,904

Peer Comparison

Commodities › Fertilizers & Agrochemicals › Fertilizers

Coromandel International peer comparison
1,996.0037.7258,8944.390.56%16.40%22.00%33,2421,508
757.30—49,00336.910.03%−2.94%4.02%5,769−88
371.557.7914,8861.311.35%20.00%25.20%20,7101,911
142.0817.3314,7552.071.08%16.20%15.40%23,939852
195.1443.088,9549.350.26%31.30%19.30%2,139203
246.1731.527,61011.140.21%38.20%27.20%2,649241
103.9412.165,7341.092.25%7.84%10.40%18,466473
Median 7 companies246.1724.4214,7554.390.56%16.40%19.30%18,466473

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

54 Average

Data confidence 100/100

Category scores

Quality
49
Average
Returns, margins, earnings quality 22% weight
Valuation
48
Average
Cheap vs sector & own history 24% weight
Growth
63
Good
Sales & profit trajectory 9% weight
Financial Health
50
Average
Solvency, leverage, coverage 9% weight
Momentum
55
Average
Trend strength, vol-adjusted 12% weight
Ownership
56
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish2512
OscillatorsNeutral252
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
64.85
Neutral
MACD (12,26,9)
50.05
Bullish
SMA (50)
1,845.80
Bullish
SMA (200)
1,979.67
Bullish

As of

Analyst Rating

Based on 9 analysts
BUY89%

8 of 9 analysts rate Buy, 1 Hold, 0 Sell.

As of

BUY
8
89%
HOLD
1
11%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+10.61%
5Y+17.29%
3Y+2.04%
1Y+30.70%
TTM+16.15%

Net profit

Net profit growth by window
10Y+18.19%
5Y+7.39%
3Y−1.94%
1Y−7.64%
TTM−36.67%

Operating cash flow

Operating cash flow growth by window
10Y+56.22%
5Y−17.79%
3Y+38.14%
1Y−36.77%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+3.57 pp
5Y−3.75 pp
3Y+0.48 pp
1Y−0.43 pp
TTM−1.68 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹10,031 Cr
Mar 2018₹11,083 Cr
Mar 2019₹13,225 Cr
Mar 2020₹13,137 Cr
Mar 2021₹14,182 Cr
Mar 2022₹19,111 Cr
Mar 2023₹29,628 Cr
Mar 2024₹22,058 Cr
Mar 2025₹24,085 Cr
Mar 2026₹31,480 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹477 Cr
Mar 2018₹691 Cr
Mar 2019₹720 Cr
Mar 2020₹1,065 Cr
Mar 2021₹1,329 Cr
Mar 2022₹1,528 Cr
Mar 2023₹2,013 Cr
Mar 2024₹1,641 Cr
Mar 2025₹2,055 Cr
Mar 2026₹1,898 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹890 Cr −10.7% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 17 Nov 2026
AI opinion · based on fundamentals
Risk medium

Coromandel International Ltd trades at ₹1,973.5 as of 2026-11-17 with a market cap of ₹58,230 crore and a P/E (TTM) of 37.3x. The company has delivered strong long-term sales and profit compounding (11% and 19% over 10 years respectively) but faces a sharp TTM profit decline of -25% even as TTM sales grew 16%, pointing to margin compression.

Bull Case 8
  • Strong long-term profit compounding at 19% CAGR over 10 years demonstrates sustained earnings growth capacity
  • Minimal leverage with a debt-to-equity ratio of just 0.11, providing financial flexibility and resilience through commodity cycles
  • ROCE of 21.08% indicates efficient capital deployment well above typical cost of capital
  • 10-year average ROE of 22% reflects consistently high returns on shareholder equity over a full business cycle
  • TTM revenue growth of 16% shows top-line momentum is intact despite profit headwinds
  • 5-year compounded sales growth of 17% indicates a meaningful structural expansion in the business over the medium term
  • Stock price CAGR of 23% over 10 years and 20% over 5 years reflects long-term wealth creation track record
  • Trading 21% below its 52-week high of ₹2,499, offering a more moderate entry valuation relative to recent peaks
Bear Case 8
  • TTM profit has declined 25% year-on-year, a sharp earnings contraction that raises margin sustainability concerns
  • P/E of 37.3x is elevated, especially given the -25% TTM profit decline — the stock is priced for growth that is currently absent
  • 3-year compounded profit growth is -1%, indicating earnings stagnation over the medium term
  • Last year ROE of 16% has deteriorated from the 10-year average of 22% and 5-year average of 20%, signalling declining return efficiency
  • 1-year stock CAGR of -12% reflects negative recent price momentum and potential de-rating risk
  • Dividend yield of just 0.56% offers minimal income cushion for investors during periods of capital depreciation
  • Price-to-book ratio of 4.34x is relatively rich for a commodities-sector company where asset-heavy valuations typically command lower multiples
  • Wide gap between TTM sales growth of 16% and TTM profit decline of -25% suggests significant cost or input price pressures are eroding profitability

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

21h ago

TL;DR: Recent news flow for Coromandel International is largely procedural, with a board re-appointment vote and a quarterly investor presentation. The sole headwind is a modest ₹2.51 Cr GST demand that management considers defensible. No material positive catalysts have emerged in this batch of updates. Investors should watch the Q2FY27 results call on November 12 for operational and financial signals.

Headwinds 1
  • GST demand of ₹2.51 Cr Oct 24

    Coromandel International received a GST demand of ₹2.51 crore for FY22-FY25 over alleged wrongful ITC availment. The company says it has a strong case to defend and expects no significant financial impact.

Neutral 2
  • Shareholder vote for director re-appointment Nov 11

    Coromandel issued a postal ballot notice seeking shareholder approval for re-appointing Sudarshan Venu as Independent Director for a second five-year term.

  • Q2FY27 investor presentation uploaded Nov 11

    Coromandel uploaded its Q2FY27 investor presentation ahead of the results conference call scheduled for November 12, 2026.

Quarterly Results

₹ Cr
COROMANDEL quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
6,988
5,464
3,913
4,729
7,433
6,935
4,988
7,042
9,654
8,779
6,004
8,165
10,294
Expenses
5,933
5,115
3,650
4,238
6,471
6,222
4,579
6,260
8,508
7,980
5,516
7,409
9,352
Operating Profit
1,055
349
263
490
962
713
409
782
1,147
800
488
756
942
OPM %
15%
6%
7%
10%
13%
10%
8%
11%
12%
9%
8%
9%
9%
Other Income
45
59
84
54
65
114
473
84
116
83
64.5
50
54.26
Interest
46
38
62
57
66
73
66
68
102
84
89
89
138
Depreciation
54
64
63
65
69
71
85
121
102
147
165
203
152
Exceptional Items
—
—
—
—
—
—
—
—
—
—
−70.56
—
—
PBT
1,000
306
222
422
892
683
731
677
1,059
653
228
514
706
Tax %
25%
25%
26%
27%
26%
26%
21%
26%
25%
25%
50%
26%
26%
Net Profit
755
228
164
309
659
508
578
502
793
488
115
382
523
EPS (₹)
25.71
7.85
5.45
10.56
22.55
17.37
19.67
17.13
27.31
17.15
4.74
12.91
18.11
YoY Sales growth
−31
−34
−29
−17
6
27
27
49
30
27
20
16
7

Profit & Loss

₹ Cr
COROMANDEL profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
11,306
11,481
10,031
11,083
13,225
13,137
14,182
19,111
29,628
22,058
24,085
31,480
33,242
Expenses
10,450
10,712
9,048
9,822
11,775
11,400
12,193
16,954
26,726
19,678
21,508
28,248
30,257
Operating Profit
856
769
983
1,261
1,450
1,737
1,989
2,156
2,902
2,380
2,577
3,232
2,985
OPM %
8%
7%
10%
11%
11%
13%
14%
11%
10%
11%
11%
10%
9%
Other Income
50
87
54
55
8
35
76
141
171
223
703
262
181
Interest
210
221
224
178
251
235
106
75
190
187
262
343
400
Depreciation
105
106
101
99
114
158
173
173
182
229
290
534
666
PBT
592
529
712
1,038
1,093
1,379
1,786
2,050
2,701
2,188
2,728
2,617
2,100
Tax %
32%
32%
33%
33%
34%
23%
26%
25%
25%
25%
25%
27%
—
Net Profit
402
357
477
691
720
1,065
1,329
1,528
2,013
1,641
2,055
1,898
1,508
EPS (₹)
13.80
12.27
16.35
23.64
24.63
36.36
45.30
52.08
68.46
55.78
70.14
66.31
52.91
Div. Payout %
33%
33%
31%
27%
26%
33%
26%
23%
18%
11%
21%
3%
—
Sales growth
12
2
−13
10
19
−1
8
35
55
−26
9
31
16

Balance Sheet

₹ Cr
COROMANDEL balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
29
29
29
29
29
29
29
29
29
29
29
30
30
Reserves
2,173
2,605
2,862
2,867
3,329
4,288
5,121
6,329
7,878
9,390
11,058
12,528
13,380
Borrowings
2,288
2,677
2,228
2,728
2,954
2,019
385
395
393
492
780
1,506
1,661
Other Liabilities
3,872
3,871
3,526
4,224
4,261
3,812
3,360
4,532
5,934
5,933
7,049
10,397
12,876
Total Liabilities
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,461
27,946
Fixed Assets
1,380
1,320
1,328
1,327
1,309
2,032
2,015
2,092
2,200
3,112
4,139
6,737
6,865
CWIP
46
42
22
48
191
65
90
141
399
235
396
348
615
Investments
352
477
388
221
201
211
214
243
287
854
1,031
2,044
1,715
Other Assets
6,583
7,343
6,907
8,252
8,873
7,840
6,576
8,809
11,348
11,644
13,351
15,331
18,752
Total Assets
8,362
9,182
8,645
9,848
10,574
10,149
8,895
11,285
14,235
15,845
18,917
24,461
27,946

Cash Flow

₹ Cr
COROMANDEL cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
86
18
915
263
526
1,862
4,150
2,078
591
1,428
2,464
1,558
Investing
−216
−61
−79
38
−597
−220
−1,245
−1,622
640
−1,333
−2,638
−559
Financing
−64
8
−864
−1
−244
−1,723
−2,263
−443
−543
−363
−698
−831
Net Cash Flow
−194
−34
−28
300
−314
−82
642
14
688
−269
−872
168
Free Cash Flow
−6
−89
834
134
255
1,606
3,958
1,801
22
910
2,030
22
CFO/EBITDA
27
25
120
49
62
128
232
119
45
86
123
71

Ratios

COROMANDEL financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
47
52
59
52
50
48
14
5
7
23
19
24
Inventory Days
96
98
88
109
127
109
98
94
69
102
98
111
Days Payable
131
135
150
162
147
135
110
100
83
119
123
136
Cash Conversion Cycle
12
15
−3
−2
30
22
2
−1
−7
6
−7
−1
Working Capital Days
11
24
40
27
42
65
64
41
37
46
28
35
ROCE %
19%
15%
18%
23%
23%
26%
32%
35%
38%
26%
23%
22%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Coromandel International insights

65 extracted metrics across FY12–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 56.34%
  • DIIs 20.48%
  • FIIs 11.33%
  • Public 7.31%
  • Others 4.53%

0.01% of promoter holding pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Coromandel International

What does Coromandel International Ltd do?
Business Segments a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, the largest…
Where is Coromandel International Ltd (COROMANDEL) listed?
Coromandel International Ltd trades as COROMANDEL on the NSE and under code 506395 on the BSE.
Which sector does Coromandel International Ltd belong to?
Coromandel International Ltd is classified under the Commodities sector, in the Fertilizers & Agrochemicals industry.
What is the market capitalisation of Coromandel International Ltd?
Coromandel International Ltd has a market capitalisation of ₹58,894 Cr as of 20 Nov 2026, which places it in the Midcap band.
What is the PE ratio of Coromandel International Ltd?
Coromandel International Ltd trades at a PE ratio of 37.72 as of 20 Nov 2026, on earnings per share of ₹52.91, against a book value of ₹454.48 per share.
What is the 52-week high and low of Coromandel International Ltd?
Over the last 52 weeks Coromandel International Ltd has traded between ₹1,651.1 and ₹2,499 as of 20 Nov 2026.
Does Coromandel International Ltd pay dividends?
Coromandel International Ltd has a dividend yield of 0.56%.
What is the Return on Equity (ROE) of Coromandel International Ltd?
Coromandel International Ltd reported a return on equity of 16.40%. Its debt-to-equity ratio is 0.12.

Company Information

Business Segments a) Nutrient and Other Allied Business (88% in FY26 vs 90% in FY25):: i) Fertilizers: It manufactures NPK, DAP, SSP, MOP, and urea. It is India's 2nd-largest manufacturer and marketer of phosphatic fertilizers, the largest manufacturer and marketer of SSP, the largest private-sector NPK player, and a pioneering leader in the Nano DAP segment. It also holds a 35% share in the unique products segment and a 17.5% market share on a consumption basis. ii) Specialty Nutrients: The company is the pioneer & market leader in India's specialty nutrients segment, offering water-soluble fertilizers, secondary and micronutrients, and nano fertilizer products. iii) Organic Fertilizers: The company markets organic fertilizers, producing a range of products derived from natural sources such as city waste, sugarcane molasses and its by-products, oil cakes, and gypsum. b) Crop Protection (12% in FY26 vs 10% in FY25):: i) Crop Protection: The company manufactures and markets a range of insecticides, fungicides, herbicides, plant growth regulators, technicals and formulations in India and international markets. It is the country's 4th-largest agrochemical player by value, with the capability to manufacture 20 technicals and intermediates. It is also the 2nd-largest manufacturer of Malathion globally and a major manufacturer of Phenthoate in Asia. ii) Bio Products: Bio Products business focuses on plant-based extracts for agricultural applications, offering a comprehensive portfolio of biopesticides based on Azadirachtin, plant-derived biostimulants, anti-transpirants and non-ionic spreaders. It holds a global leadership position in the Azadirachtin market, with a presence across more than 40 countries in the Americas, Europe and Asia. Sale Volumes (in Lakh MT): NPK+DAP: 42.77 in FY26 vs 39.88 in FY25 SSP: 8.41 in FY26 vs 7.73 in FY25 MOP: 0.67 in FY26 vs 0.69 in FY25 Urea: 22.65 in FY26 vs 13.59 in FY25 Geographical Split Domestic: 94% in FY26 vs 95% in FY25 Exports: 6% in FY26 vs 5% in FY25 Retail Presence The company operates India's largest agri-retail network with over 1,200 agri-retail outlets across Andhra Pradesh, Telangana, Karnataka, Tamil Nadu and Maharashtra. It is supported by over 3,000 marketing professionals and serves more than 5 Mn farmers across its operating markets. It has a network of 12,000 channel partners. New Product Launches In FY26, Coromandel expanded its portfolio with new launches across Specialty Nutrients, Crop Protection and Bio Products. It's key additions included Fertinex 28:28:0, GypMax, Novonese, Organovita and Summit in Specialty Nutrients; Daliso, Ghibli, Chhaava and Invicto in Crop Protection; and CoroBT, GroBT, Coroscens, CoroShakti and other biological solutions to strengthen its bio-products portfolio. Manufacturing Capabilities The company operates 21 manufacturing facilities across India, with a total capacity of: Fertilizers: 3.5 Mn MT SSP: 1 Mn MT Specialty Nutrients: 87,500 MT Nano Fertilizers: 10,000 KL Crop Protection Chemicals: 0.87 Lakh MT Bio Products: 22.5 MT Expansion & Backward Integration The company commissioned a 2,000 TPD sulphuric acid plant and a 650 TPD phosphoric acid plant at Kakinada in Q4 FY26, for Rs. 1,100 Cr. It also advanced construction of the 7.5 lakh TPA NPK granulation Train H at Kakinada, expected to increase the site's total fertilizer capacity to 30 lakh TPAby Q4 FY27. Additionally, its Senegal rock phosphate project, where the company holds a 53.8% stake, commissioned a fixed processing plant and ramped up production to secure raw material supplies for the Kakinada phosphoric acid facility. It also added a 9 KTPA technical plant at Dahej for off-patent fungicides, along with capacity additions for key technical molecules at Ankleshwar and a herbicide block expansion at Sarigam. Acquisitions In Aug 2025, the company acquired a 53.13% controlling stake in NACL Industries for Rs. 820 Cr. MoU In Nov 2025, the company signed a non-binding MoU with the Andhra Pradesh Economic Development Board to explore investments of up to Rs. 2,000 Cr in Andhra Pradesh. Focus The company expects a 20-25% revenue growth in the crop protection business.

CEO Mr. Arun Alagappan
Employees 5,540
Listed 31 May 1995
Face Value ₹1
Shares Outstanding 29,50,60,899

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/COROMANDEL.md for Coromandel International Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More